Perceptive Advisors - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 197 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is 1.31 and the average weighting 0.4%.

Quarter-by-quarter ownership
Perceptive Advisors ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$25,279,318
+172.3%
282,720
+248.7%
0.84%
+213.4%
Q2 2023$9,284,594
-74.2%
81,074
-68.9%
0.27%
-74.7%
Q1 2023$35,954,058
-57.3%
260,858
-59.8%
1.06%
-55.0%
Q4 2022$84,129,815
+200.8%
649,250
+156.6%
2.36%
+190.9%
Q3 2022$27,967,000
+6543.0%
253,000
+153.0%
0.81%
+6666.7%
Q1 2019$421,000
-98.9%
100,000
-90.8%
0.01%
-99.4%
Q2 2017$36,743,000
-29.9%
1,089,961
-38.5%
1.85%
-38.1%
Q1 2017$52,422,000
-31.2%
1,771,029
-36.3%
2.99%
-44.9%
Q4 2016$76,225,000
-63.4%
2,780,729
-18.1%
5.42%
-59.7%
Q3 2016$208,506,000
-11.6%
3,395,236
-72.5%
13.46%
-17.7%
Q2 2016$235,816,000
+175.6%
12,365,816
+182.1%
16.35%
+117.8%
Q1 2016$85,559,000
-21.9%
4,383,128
+54.3%
7.50%
-7.4%
Q4 2015$109,603,000
-44.7%
2,840,928
-54.0%
8.11%
+2.4%
Q3 2015$198,116,000
+96.7%
6,169,856
+86.4%
7.92%
+30.5%
Q2 2015$100,709,000
+156.7%
3,309,528
+12.0%
6.06%
+98.9%
Q1 2015$39,238,000
-16.9%
2,954,652
-9.4%
3.05%
-23.0%
Q4 2014$47,207,000
-41.8%
3,262,352
-15.2%
3.96%
-54.6%
Q3 2014$81,165,000
+6.5%
3,846,691
+50.4%
8.72%
+16.6%
Q2 2014$76,217,000
-1.8%
2,558,478
-20.8%
7.48%
-8.3%
Q1 2014$77,595,000
-7.9%
3,228,979
-21.9%
8.15%
-19.4%
Q4 2013$84,222,000
-62.8%
4,134,579
-82.1%
10.12%
+8.4%
Q3 2013$226,641,000
+75.8%
23,044,138
+579.8%
9.33%
-28.2%
Q2 2013$128,932,0003,390,08813.00%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q3 2016
NameSharesValueWeighting ↓
Casdin Capital, LLC 1,010,330$122,472,20313.56%
Finepoint Capital LP 145,357$17,620,1768.78%
Avoro Capital Advisors LLC 4,025,000$487,910,5007.61%
Saturn V Capital Management LP 118,401$14,352,5696.01%
Ghost Tree Capital, LLC 150,000$18,183,0005.98%
Ikarian Capital, LLC 3,673$44,524,1065.36%
ACUTA CAPITAL PARTNERS, LLC 550$7,580,6505.08%
Eagle Health Investments LP 174,212$21,117,9794.65%
Boxer Capital, LLC 600,000$72,732,0003.87%
GREAT POINT PARTNERS LLC 165,200$20,025,5443.65%
View complete list of SAREPTA THERAPEUTICS INC shareholders